These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3067104)

  • 21. Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.
    Paetsch PR; Greenshaw AJ
    Cell Mol Neurobiol; 1993 Jun; 13(3):203-15. PubMed ID: 8242685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional distribution of monoamines and dopamine D1- and D2-receptors in the striatum of the rat.
    Russell VA; Allin R; Lamm MC; Taljaard JJ
    Neurochem Res; 1992 Apr; 17(4):387-95. PubMed ID: 1387462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride.
    Lidow MS; Goldman-Rakic PS; Rakic P; Innis RB
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6412-6. PubMed ID: 2548214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competition by estrogens for catecholamine receptor binding in vitro.
    Paden CM; McEwen BS; Fishman J; Snyder L; DeGroff V
    J Neurochem; 1982 Aug; 39(2):512-20. PubMed ID: 7086432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of norepinephrine activity in the regulation of alpha 1 adrenergic receptors in the medial preoptic nucleus of estradiol-treated rats.
    Sortino MA; Weiland NG; Wise PM
    Life Sci; 1989; 44(17):1223-9. PubMed ID: 2541289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective labeling of alpha-noradrenergic receptors in rat brain with [3H]dihydroergokryptine.
    Greenberg DA; Snyder SH
    Life Sci; 1977 Mar; 20(6):927-31. PubMed ID: 191710
    [No Abstract]   [Full Text] [Related]  

  • 27. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
    Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release.
    Nielsen EB; Nielsen M; Braestrup C
    Psychopharmacology (Berl); 1983; 81(1):81-5. PubMed ID: 6415736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related changes in rat brain dopaminergic receptors.
    Petkov VV; Petkov VD; Grahovska T; Konstantinova E
    Acta Physiol Pharmacol Bulg; 1984; 10(4):16-27. PubMed ID: 6535368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: an electrophysiological study.
    Yang CR; Mogenson GJ
    Brain Res; 1990 Aug; 524(2):271-81. PubMed ID: 1981327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
    Hallman H; Jonsson G
    Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catecholamine synthesis inhibitors acutely modulate [3H]estradiol binding by specific brain areas and pituitary in ovariectomized rats.
    Thompson MA; Woolley DE; Gietzen DW; Conway S
    Endocrinology; 1983 Sep; 113(3):855-65. PubMed ID: 6135604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat.
    Kostrzewa RM; Saleh MI
    Neuropharmacology; 1989 Aug; 28(8):805-10. PubMed ID: 2571103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
    Dewar KM; Montreuil B; Grondin L; Reader TA
    J Pharmacol Exp Ther; 1989 Aug; 250(2):696-706. PubMed ID: 2527300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of dopaminergic terminal excitability by D1 selective agents: further characterization.
    Diana M; Young SJ; Groves PM
    Neuroscience; 1991; 42(2):441-9. PubMed ID: 1680226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative distributions of dopamine D-1 and D-2 receptors in the cerebral cortex of rats, cats, and monkeys.
    Richfield EK; Young AB; Penney JB
    J Comp Neurol; 1989 Aug; 286(4):409-26. PubMed ID: 2506254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum.
    Csernansky JG; Friedhoff AJ; Bonnet KA
    Biochem Biophys Res Commun; 1982 Mar; 105(1):117-20. PubMed ID: 6124243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.